SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
The Tradition of Stone: A Gander at Notable Structures Through the Ages - 2Famous SUVs With Low Energy Utilization In 2024
- 3The 10 Most Noteworthy Games in History
- 4SpaceX launches Italian Earth-observing satellite to orbit on the 1st mission of 2026 (video)
- 5A top Marine shares his secrets to keeping fit at 50
- When fake data is a good thing – how synthetic data trains AI to solve real problems
- Nature carves colossal snowman in Siberia | Space photo of the day for Jan. 2, 2026
- German finance minister seeks better market access in China talks
- Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
- Becoming amazing at Arranging Pay Raises
- Step by step instructions to Protect Your Retirement with Senior Protection.
- Modern surgery began with saws and iron hands – how amputation transformed the body in the Renaissance
- A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
- 10 Picturesque Campgrounds That Will Raise Your Outside Involvement with American
